These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8810740

  • 1. 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
    Gourmelen M, Saint-Jacques I, Morineau G, Soliman H, Julien R, Fiet J.
    Eur J Endocrinol; 1996 Aug; 135(2):238-44. PubMed ID: 8810740
    [Abstract] [Full Text] [Related]

  • 2. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA.
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [Abstract] [Full Text] [Related]

  • 3. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM, Corrie JE, Shackleton CH, Edwards CR.
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [Abstract] [Full Text] [Related]

  • 4. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G, Pascoe L, Marc JM, Caillette A, Krozowski Z, Corvol P, Fiet J.
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [Abstract] [Full Text] [Related]

  • 5. Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.
    New MI, Stoner E, DiMartino-Nardi J.
    Clin Exp Hypertens A; 1986 Aug; 8(4-5):751-72. PubMed ID: 3463439
    [Abstract] [Full Text] [Related]

  • 6. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
    Odermatt A, Dick B, Arnold P, Zaehner T, Plueschke V, Deregibus MN, Repetto H, Frey BM, Frey FJ, Ferrari P.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
    [Abstract] [Full Text] [Related]

  • 7. Apparent mineralocorticoid excess syndromes.
    Shimojo M, Stewart PM.
    J Endocrinol Invest; 1995 Mar; 18(7):518-32. PubMed ID: 9221270
    [Abstract] [Full Text] [Related]

  • 8. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
    Stewart PM, Whorwood CB, Walker BR.
    Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018
    [Abstract] [Full Text] [Related]

  • 9. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension.
    Walker BR, Stewart PM, Shackleton CH, Padfield PL, Edwards CR.
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):221-7. PubMed ID: 8370136
    [Abstract] [Full Text] [Related]

  • 10. Apparent mineralocorticoid excess.
    Funder JW.
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
    [Abstract] [Full Text] [Related]

  • 11. Apparent mineralocorticoid excess type II.
    Mantero F, Tedde R, Opocher G, Dessi Fulgheri P, Arnaldi G, Ulick S.
    Steroids; 1994 Feb; 59(2):80-3. PubMed ID: 8191552
    [Abstract] [Full Text] [Related]

  • 12. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB, Stewart PM.
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [Abstract] [Full Text] [Related]

  • 13. Cortisol to cortisone: glucocorticoid to mineralocorticoid.
    Stewart PM, Mason JI.
    Steroids; 1995 Jan; 60(1):143-6. PubMed ID: 7792800
    [Abstract] [Full Text] [Related]

  • 14. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
    Mosso L, Carvajal C, Campino C, Rojas A, González A, Barraza A, Montero J, Fardella C.
    Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501
    [Abstract] [Full Text] [Related]

  • 15. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC, Mune T, Rogerson FM, Kayes KM, Agarwal AK.
    Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285
    [Abstract] [Full Text] [Related]

  • 16. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M, Delitala G, Sorba G, Cossu M, Satta R, Tedde R, Pala A, Shackleton CH.
    J Endocrinol Invest; 2000 Jan; 23(7):457-62. PubMed ID: 11005270
    [Abstract] [Full Text] [Related]

  • 17. 11 beta-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy.
    Walker BR, Williamson PM, Brown MA, Honour JW, Edwards CR, Whitworth JA.
    Hypertension; 1995 Apr; 25(4 Pt 1):626-30. PubMed ID: 7721407
    [Abstract] [Full Text] [Related]

  • 18. The cortisol-cortisone shuttle and hypertension.
    Stewart PM, Edwards CR.
    J Steroid Biochem Mol Biol; 1991 Apr; 40(4-6):501-9. PubMed ID: 1958552
    [Abstract] [Full Text] [Related]

  • 19. New findings in apparent mineralocorticoid excess.
    DiMartino-Nardi J, Stoner E, Martin K, Balfe JW, Jose PA, New MI.
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):49-62. PubMed ID: 2820623
    [Abstract] [Full Text] [Related]

  • 20. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC.
    Am J Med Sci; 2001 Dec; 322(6):308-15. PubMed ID: 11780688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.